Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Officials target drug-dealing doctors who prescribe addictive pain pills

      Officials target drug-dealing doctors who prescribe addictive pain pills

      Ruby Khatun Khatun2 Jan 2018 10:00 AM IST
      PITTSBURGH: Federal prosecutors say a strategy that gives them better access to drug and healthcare data is helping them stop doctors who...
      Abbott India collaborates with Gujarat FDCA to train new medical device inspectors

      Abbott India collaborates with Gujarat FDCA to train new medical device inspectors

      Ruby Khatun Khatun2 Jan 2018 10:00 AM IST
      Abbott India collaborates with Gujarat FDCA to provided training to around 62 newly recruited drug inspectors on auditing a medical device...
      Tax on medical devices to resume after 2 year suspension

      Tax on medical devices to resume after 2 year suspension

      Ruby Khatun Khatun2 Jan 2018 9:30 AM IST
      BOSTON: While much of corporate America will enjoy a tax cut in the new year, one industry is getting a tax increase it has fought hard but so far...
      Zydus gets USFDA final approval for Valacyclovir tablets

      Zydus gets USFDA final approval for Valacyclovir tablets

      Ruby Khatun Khatun1 Jan 2018 1:44 PM IST
      Ahmedabad: Zydus Pharmaceuticals USA Inc has received the final approval from the USFDA to market Valacyclovir Tablets USP in strengths of 500 mg and...
      Jubilant receives sNDA approval for new indications from USFDA for DRAXIMAGE

      Jubilant receives sNDA approval for new indications from USFDA for DRAXIMAGE

      Ruby Khatun Khatun1 Jan 2018 11:30 AM IST
      Noida: Jubilant Pharma Limited, a material wholly owned subsidiary of Jubilant Life Sciences Ltd, through one of its wholly-owned subsidiaries, has...
      Siemens to gauge interest of state funds in Healthineers IPO: CEO

      Siemens to gauge interest of state funds in Healthineers IPO: CEO

      Ruby Khatun Khatun1 Jan 2018 10:30 AM IST
      FRANKFURT: Siemens will test the appetite of sovereign wealth funds ahead of the planned listing of its healthcare unit Healthineers next year, its...
      NDA filing by GW Pharmaceuticals for Epidiolex accepted by USFDA

      NDA filing by GW Pharmaceuticals for Epidiolex accepted by USFDA

      Ruby Khatun Khatun1 Jan 2018 10:00 AM IST
      LONDON: GW Pharmaceuticals plc announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with Priority Review its recently...
      Guerbet LLC, takes note of new FDA requirements for Gadolinium-based contrast agents in MRI

      Guerbet LLC, takes note of new FDA requirements for Gadolinium-based contrast agents in MRI

      Ruby Khatun Khatun1 Jan 2018 9:30 AM IST
      PRINCETON, N.J: Guerbet LLC takes note of the drug safety communication issued by the U.S. Food and Drug Administration (FDA), regarding...
      Code for pharma marketing practices may be enforced soon

      Code for pharma marketing practices may be enforced soon

      Ruby Khatun Khatun31 Dec 2017 12:28 PM IST
      New Delhi: A uniform code for pharma marketing practices could be imposed soon as a revised final draft of a code regulating promotional practices in...
      Mylans Generic version of Allergans vaginal cream gets USFDA nod

      Mylan's Generic version of Allergan's vaginal cream gets USFDA nod

      Ruby Khatun Khatun31 Dec 2017 11:00 AM IST
      Mylan NV said the U.S. Food and Drug Administration had granted it the approval for a generic version of Allergan’s Estrace cream for vaginal...
      AstraZeneca sells four NDAs for 46.5 Million to ANI Pharmaceuticals

      AstraZeneca sells four NDAs for 46.5 Million to ANI Pharmaceuticals

      Ruby Khatun Khatun31 Dec 2017 10:30 AM IST
      BAUDETTE: ANI Pharmaceuticals, Inc. announced that it has acquired the NDAs and U.S. rights to market ATACAND®, ATACAND HCT®, ARIMIDEX®, and CASODEX®...
      Patients save Rs 11,365 crores due to price cap on drugs, medical devices: Govt

      Patients save Rs 11,365 crores due to price cap on drugs, medical devices: Govt

      Ruby Khatun Khatun31 Dec 2017 10:01 AM IST
      New Delhi: Capping of prices of medicines and medical devices, including stents and knee implants, has helped patients save a total of Rs 11,365.61...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok